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Neurobiology of Disease

Repeated N-Acetylcysteine Administration Alters PlasticityDependent Effects of Cocaine
Aric Madayag, Doug Lobner, Kristen S. Kau, John R. Mantsch, Omer Abdulhameed, Matthew Hearing, Mark D. Grier,
and David A. Baker
Department of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233

Cocaine produces a persistent reduction in cystine– glutamate exchange via system xc⫺ in the nucleus accumbens that may contribute to
pathological glutamate signaling linked to addiction. System xc⫺ influences glutamate neurotransmission by maintaining basal, extracellular glutamate in the nucleus accumbens, which, in turn, shapes synaptic activity by stimulating group II metabotropic glutamate
autoreceptors. In the present study, we tested the hypothesis that a long-term reduction in system xc⫺ activity is part of the plasticity
produced by repeated cocaine that results in the establishment of compulsive drug seeking. To test this, the cysteine prodrug
N-acetylcysteine was administered before daily cocaine to determine the impact of increased cystine– glutamate exchange on the development of plasticity-dependent cocaine seeking. Although N-acetylcysteine administered before cocaine did not alter the acute effects of
cocaine on self-administration or locomotor activity, it prevented behaviors produced by repeated cocaine including escalation of drug
intake, behavioral sensitization, and cocaine-primed reinstatement. Because sensitization or reinstatement was not evident even 2–3
weeks after the last injection of N-acetylcysteine, we examined whether N-acetylcysteine administered before daily cocaine also prevented
the persistent reduction in system xc⫺ activity produced by repeated cocaine. Interestingly, N-acetylcysteine pretreatment prevented
cocaine-induced changes in [ 35S]cystine transport via system xc⫺, basal glutamate, and cocaine-evoked glutamate in the nucleus accumbens when assessed at least 3 weeks after the last N-acetylcysteine pretreatment. These findings indicate that N-acetylcysteine
selectively alters plasticity-dependent behaviors and that normal system xc⫺ activity prevents pathological changes in extracellular
glutamate that may be necessary for compulsive drug seeking.
Key words: extrasynaptic glutamate; addiction; system xc⫺; nucleus accumbens; nonvesicular; cystine– glutamate antiporter

Introduction
Repeated cocaine alters glutamate neurotransmission even after
protracted withdrawal (Wolf et al., 2004; Kalivas et al., 2005), and
this likely contributes to addiction because abnormal activation
of corticostriatal pathways correlates with craving in humans
(Breiter et al., 1997; Volkow et al., 1999, 2005) and is necessary for
cocaine seeking in rodents (Park et al., 2002; McFarland et al.,
2003; Schmidt et al., 2005). Revealing cellular mechanisms underlying altered corticostriatal activation should advance our understanding of the neurobiological basis of addiction and identify
novel therapeutic targets (Volkow and Fowler, 2000; Dackis,
2004).
Models of pathological glutamate signaling proposed to underlie addiction need to account for the existence of multiple
pools of extracellular glutamate. Aside from synaptic glutamate
maintained by vesicular release, extrasynaptic glutamate is sustained primarily by nonvesicular release (Herrera-Marschitz et
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al., 1996; Timmerman and Westerink, 1997). In support, basal
extrasynaptic glutamate sampled using microdialysis are mostly
independent of vesicular glutamate (Westerink, 1995). Glutamate transporters may partition the two pools by limiting glutamate overflow from the synapse into extrasynaptic compartments (Danbolt, 2001), and restricting entry of nonvesicular
glutamate into synapses (Jabaudon et al., 1999). Although confined to the extrasynaptic compartment, nonvesicular glutamate
regulates neurotransmission by stimulating group II metabotropic glutamate receptors (mGluRs) (Xi et al., 2002a; Baker et
al., 2003), which are extrasynaptic receptors capable of inhibiting
vesicular release (Baskys and Malenka, 1991; Cochilla and Alford,
1998; Schoepp, 2001). Thus, extrasynaptic receptors permit cross
talk between the two pools and indicate that altered nonvesicular
glutamate release may contribute to pathological glutamate signaling linked to addiction.
Cystine– glutamate exchange via system xc⫺ may be critical in
the capacity of extrasynaptic glutamate to regulate corticostriatal
signaling in the normal and pathological states. First, nonvesicular release from cystine– glutamate exchange maintains basal extracellular glutamate in the nucleus accumbens (Baker et al.,
2002; Xi et al., 2002a), and thereby regulates the extent of endogenous group II mGluR stimulation (Baker et al., 2002; Melendez
et al., 2005; Moran et al., 2005). Repeated cocaine blunts system
xc⫺ activity, which leads to reduced basal and increased cocaine-
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evoked glutamate in the nucleus accumbens that persists for at
least 3 weeks after the last cocaine treatment (Baker et al., 2003).
These changes are relevant for drug seeking because
N-acetylcysteine, a cysteine prodrug used to drive system xc⫺
(Williamson and Meister, 1981; Meister, 1985; Pileblad and Magnusson, 1992), blocks cocaine-evoked glutamate in the nucleus
accumbens and subsequent cocaine-induced reinstatement
(Baker et al., 2003).
In these studies, we tested the hypothesis that reduced system
xc⫺ activity is part of the pathological plasticity produced by
repeated cocaine that results in compulsive drug seeking. To explore this, we assessed the capacity of N-acetylcysteine administered before daily cocaine to prevent behavioral plasticity and
reduced function of system xc⫺. These data have the potential to
extend our earlier observation that acute N-acetylcysteine administered before testing blocks reinstatement by demonstrating
that plasticity-dependent behavior fails to materialize in the absence of reduced system xc⫺ activity, even when testing occurs
weeks after the last N-acetylcysteine treatment.

Materials and Methods
Animals

These experiments used male Sprague Dawley rats (Harlan, Indianapolis,
IN) weighing 275–325 g on arrival. Rats were individually housed in a
temperature-controlled colony room with a 12 h reversed light/dark cycle. Housing conditions and experimental protocols were approved by
the Marquette University Institutional Animal Care and Use Committee
and performed according to the National Institutes of Health Guide for
the Care and Use of Laboratory Animals (revised 1996).

Surgeries
Rats included in self-administration studies were implanted with indwelling catheters under ketamine HCl (100 mg/kg, i.p.; Fort Dodge
Animal Health, Fort Dodge, IA) and xylazine (2 mg/kg, i.p.; Lloyd Laboratories, Shenandoah, IA) anesthesia. A silicon tubing catheter (Dow
Corning, Midland, MI; 0.64 mm inner diameter; 1.19 mm outer diameter) was implanted such that it entered the jugular vein through the right
posterior facial vein and terminated at the right atrium. The catheter was
sutured to the vein at the entry point. The distal aspect of the catheter,
which consisted of a 22-gauge guide cannula (Plastics One, Roanoke,
VA) attached with dental acrylic to a piece of polypropylene monofilament surgical mesh (Atrium Medical, Hudson, NH), exited 2 cm posterior to the scapulae. Throughout the experiment, catheters were filled
daily with a heparin solution (83 i.u./ml; Elkins-Sinn, Cherry Hill, NJ)
and capped when disconnected from the leash/delivery line assembly.
Rats included in microdialysis studies were also implanted with indwelling bilateral guide cannulas (20 gauge, 14 mm; Plastics One) using
the following coordinates derived from Paxinos and Watson (1986):
⫹0.9 mm anterior, ⫾2.5 mm mediolateral to bregma, and ⫺4.4 mm
from the surface of the skull at a 6° angle from vertical. The placement of
the active region of the microdialysis probe, which began 2 mm beyond
the ventral tip of the guide cannulas, was primarily in the nucleus accumbens core, although regions immediately dorsal and ventral to this were
also likely sampled. After surgery, rats were given at least 5 d to recover
before testing. During this time, rats were provided acetaminophen (480
mg/L) in their drinking water and injected daily with a sterile cefazolin
antibiotic solution (15 mg, i.v.; West-Ward Pharmaceutical, Eatontown,
NJ).
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subjects received at least 150 food rewards in a session, which typically
occurred after the first session. Rats then underwent drug selfadministration training during daily 2 h sessions in which operant responses on the active lever were reinforced with an infusion of saline or
cocaine (0.5 mg 䡠 kg ⫺1 䡠 200 l ⫺1, i.v.; National Institute on Drug
Abuse, Bethesda, MD) under a fixed ratio 1 schedule of reinforcement.
Each reinforced lever response resulted in the illumination of the stimulus light located above the active lever and was followed by a 25 s time-out
period. Responding on a second, inactive lever located on the back wall
was recorded but had no programmed consequences. Acquisition of
cocaine self-administration was operationally defined as ⬍10% variation
in daily responding over at least three consecutive sessions. Once rats met
the acquisition criteria, they were advanced to maintenance sessions in
which saline or cocaine was self-administered under short- (0.5
mg 䡠 kg ⫺1 䡠 200 l ⫺1, i.v.; 2 h/d for 10 d) or extended-access conditions
(1.0 mg 䡠 kg ⫺1 䡠 200 l ⫺1, i.v.; 6 h/d for 11 d). Rats received daily
N-acetylcysteine (0 or 60 mg/kg, i.p.) 60 min before each acquisition or
maintenance self-administration session.

Experiment 1: impact of N-acetylcysteine pretreatment on
escalation of drug intake
Self-administration under extended access conditions has been shown to
produce an increase in cocaine intake that may model loss of control in
human abusers (Ahmed and Koob, 1998; Mantsch et al., 2004; Ahmed
and Cador, 2006; Kippin et al., 2006). In the current study, rats were
pretreated with saline or N-acetylcysteine (60 mg/kg, i.p.) 60 min before
self-administering saline or cocaine (1.0 mg 䡠 kg ⫺1 䡠 200 l ⫺1, i.v.; 6 h/d;
11 daily sessions). The pretreatment/self-administration drug assignments resulted in the following groups: saline–saline (N ⫽ 19), N-acetylcysteine–saline (N ⫽ 10), saline– cocaine (N ⫽ 18), and N-acetylcysteine– cocaine (N ⫽ 12). Escalation was evident as a statistically
significant increase in the number of infusions obtained relative to the
first 6 h session.

Experiment 2: impact of N-acetylcysteine pretreatment on
persistent cocaine-induced behavioral sensitization
Behavioral sensitization represents one of the most used paradigms in
attempts to identify the relevance of drug-induced plasticity and may
model changes in sensitivity to cocaine arising after repeated drug exposure (Wolf, 1998; Vanderschuren and Kalivas, 2000). On days 1–7 of the
current experiment, rats received daily injections of saline or
N-acetylcysteine (60 mg/kg, i.p.) followed 120 min later by saline or
cocaine (15 mg/kg, i.p., on days 1 and 7; 30 mg/kg, i.p., on days 2– 6).
These drug assignments resulted in the following groups: saline–saline
(N ⫽ 11), N-acetylcysteine–saline (N ⫽ 11), saline– cocaine (N ⫽ 13),
and N-acetylcysteine– cocaine (N ⫽ 15). Rats then remained in the home
cage for a 21 d drug-free period (day 28 of the experiment), and were then
challenged with saline or cocaine (15 mg/kg, i.p.) in the absence of
N-acetylcysteine pretreatment. As a result, behavioral sensitization is
assessed on day 28, which is 3 weeks after the last N-acetylcysteine
injection.
Locomotor activity was monitored using 16 Plexiglas activity chambers (22 ⫻ 43 ⫻ 33 cm 3; Omnitech Electronics, Columbus, OH). Total
distance (in centimeters) traveled was monitored using 16 photobeams
(eight on each horizontal axis) interfaced with a Digiscan monitor (Omnitech Electronics). Activity levels were recorded 60 min before and 120
min after a saline or cocaine injection. Locomotor behavior was measured on days 1, 7, and 28.

Self-administration training

Experiment 3: impact of daily N-acetylcysteine pretreatment on
persistent cocaine-evoked changes in extracellular glutamate and
reinstatement

Self-administration occurred in operant chambers (ENV-008CT; MEDAssociates, St. Albans, VT) housed in sound-attenuating cubicles (ENV016M; MED-Associates) and equipped with two retractable levers, two
stimulus lights, and a water bottle. At least 5 d after surgery, rats were
food restricted for 18 h with water available ad libitum. Rats were then
placed into the operant chambers overnight and responses on the lever
designated as active resulted in the delivery of food pellets under a fixed
ratio 1 schedule of reinforcement. Daily food training continued until

Cocaine-primed reinstatement likely provides measures of drug seeking
independent of drug reinforcement and may require reduced system xc⫺
activity that has been observed after withdrawal from repeated cocaine
(Baker et al., 2003). In the current study, microdialysis and reinstatement
data were collected in parallel from the same group of rats to better
correlate neurochemical and behavioral findings. Rats were pretreated
with saline or N-acetylcysteine (60 mg/kg, i.p.) 60 min before selfadministering saline or cocaine (0.5 mg 䡠 kg ⫺1 䡠 200 l ⫺1, i.v.; 2 h/d).
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The pretreatment/self-administration drug assignments resulted in the
following groups: saline–saline (N ⫽ 14, N-acetylcysteine–saline (N ⫽
6), saline– cocaine (N ⫽ 14), and N-acetylcysteine– cocaine (N ⫽ 7).
After self-administration, rats underwent extinction training and a subsequent microdialysis/reinstatement test day as described below.
Extinction training. After completing 10 maintenance selfadministration sessions, rats remained in their home cages for 7 d before
extinction training. A 7 d delay was used to ensure an adequate drug-free
period before reinstatement, even in rats that quickly extinguished responding. Extinction training involved placing rats into the operant
chambers for 2 h/d as described above in the self-administration section
except each active lever press now resulted in an infusion of saline. This
continued until the mean number of lever presses was ⱕ15 responses
across at least three sessions, at which point rats were tested for drugprimed reinstatement. Because the average number of extinction sessions needed to meet criteria (⫾SEM) was 11.7 ⫾ 1.10, reinstatement
testing occurred ⬃18 d after the last self-administration session.
In vivo microdialysis and reinstatement test day. On the night before the
reinstatement test, microdialysis probes, constructed as previously described (Baker et al., 2003), were inserted into indwelling guide cannula.
Rats were then housed overnight in the self-administration chambers.
The next day, dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM CaCl2,
1.2 mM MgCl2, and 0.15% PBS, pH 7.4) was pumped through the probes
at a rate of 2 l/min for at least 3 h to permit an adequate period of time
for glutamate levels to stabilize. After this, basal glutamate levels were
sampled over 60 min. Rats were then injected with cocaine (10 mg/kg,
i.p.) and the levers were extended. Extracellular glutamate and operant
responding were assessed over the next 120 min (N ⫽ 6 –14/group).
Quantification of glutamate. The concentration of glutamate in dialysis
samples was quantified by comparing peak heights from samples and
external standards using HPLC coupled to fluorescence detection. Precolumn derivatization of glutamate with opthaldehyde was performed
using a Shimadzu LC10AD VP autosampler. The mobile phase consisted
of 13% acetonitrile, 100 mM Na2HPO4, and 0.1 mM EDTA, pH 5.90.
Glutamate was separated using a reversed-phase column (4 m; 140 ⫻
6.0 mm; Phenomenex, Torrance, CA), and detected using a Shimadzu
10RF-AXL fluorescence detector with excitation and emission wavelengths of 320 and 400 nm, respectively.
Histology. Rats included in the microdialysis studies were given an
overdose of pentobarbital (60 mg/kg, i.p.), and the brains were fixed by
intracardiac infusion of 0.9% saline followed by 2.5% formalin solution.
Brains were removed and stored in 2.5% formalin for at least 7 d before
sectioning. The tissue was then blocked, and coronal sections (100 m)
were cut and stained with cresyl violet to verify probe placements.

Experiment 4: impact of N-acetylcysteine pretreatment on
persistent cocaine-induced changes in system xc⫺ activity

Repeated cocaine produces a persistent reduction in system xc⫺ activity
in the nucleus accumbens (Baker et al., 2003). In the present study,
cystine– glutamate exchange was assessed in rats pretreated with saline or
N-acetylcysteine (60 mg/kg, i.p.) 60 min before self-administering saline
or cocaine (1.0 mg 䡠 kg ⫺1 䡠 200 l ⫺1, i.v.; 6 h/d; 11 daily sessions). The
pretreatment/self-administered drug assignments resulted in the following groups: saline–saline (N ⫽ 12), N-acetylcysteine–saline (N ⫽ 5),
saline– cocaine (N ⫽ 7), and N-acetylcysteine– cocaine (N ⫽ 11). After
self-administration, rats remained in the home cage for 23–34 d. As a
result, the status of system xc⫺ was determined at least 3 weeks after the
last N-acetylcysteine treatment.
Rats were decapitated and the brains were rapidly extracted and cut
into 2 mm coronal slices using a brain matrix. Tissue punches (1.25 mm
diameter; Stoelting, Wood Dale, IL) were collected from the nucleus
accumbens core and incubated at 37°C for ⬃30 min on a nylon bolting
cloth platform, submerged beneath 2 mm of standard buffer (Lobner and
Lipton, 1993); the standard buffer contained 124 mM NaCl, 3.0 mM KCl,
1.4 mM KH2PO4, 1.3 mM MgSO4, 26 mM NaHCO3, 2.4 mM CaCl2, and 4
mM glucose, equilibrated with 95% O2, 5% CO2, pH 7.4. After a 30 min
wash, the tissue was incubated for 30 min in standard buffer containing
[ 35S]cystine (4 Ci/ml; GE Healthcare, Piscataway, NJ). D-Aspartate (1
mM) was also added to the incubation buffer to prevent uptake via XAG.
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Figure 1. N-Acetylcysteine pretreatment prevents escalation of drug intake during daily
extended-access cocaine self-administration. a, b, Data depict mean ⫾ SEM daily cocaine
intake (mg/kg, i.v.) across 11 maintenance self-administration sessions (a) and difference in
intake between days 11 and 1 to illustrate escalation in intake (b). Rats received saline (Sal) or
N-acetylcysteine (NAC) (60 mg/kg, i.p.) before daily saline or cocaine (Coc) (1.0 mg/kg, i.v./
infusion; 6 h/d) self-administration sessions. The pretreatment/self-administration drug assignments resulted in the following groups: Sal–Sal (N ⫽ 19), NAC–Sal (N ⫽ 10), Sal–Coc
(N ⫽ 18), and NAC–Coc (N ⫽ 12). Escalation is operationally defined as a significant increase in
the number of infusions obtained relative to day 1. *Significant difference from day 1 intake (a)
or rats pretreated with saline before saline self-administration training sessions (Sal–Sal) (b);
Dunnett’s t, p ⬍ 0.05. #Significant difference from NAC–Coc rats.

After 30 min incubation, the tissue punches were washed four times in
ice-cold standard buffer and dissolved in 250 l of 1% SDS. One aliquot
(100 l) was used to measure [ 35S]cystine uptake by scintillation counting; a second aliquot (100 l) was used to assess protein content by the
BCA method. Additional punches from each subject were processed as
described above with the exception that unlabeled CPG [( S)-4carboxyphenylglycine] (1 mM) was added 10 min before and for the
duration of the 30 min incubation with [ 35S]cystine (4 Ci/ml). These
values reflect labeling independent of system xc⫺ and were subtracted
from the total labeling obtained from each subject to get a measure that
solely reflected uptake through cystine– glutamate exchange.

Statistical analyses for experiments 1– 4
The SPSS statistics package was used to perform the statistical analyses.
Data were analyzed using ANOVA with drug treatment (e.g., dose of
N-acetylcysteine and cocaine) as between-subject factors and time (day
and/or 20 min interval) as a repeated factor. Significant main effects and
interactions were further evaluated using Dunnett’s t test with cocaine
controls designated as the comparison group.
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Results
Daily N-acetylcysteine pretreatment blunts cocaine-induced
behavioral plasticity
In the present studies, we tested the hypothesis that
N-acetylcysteine administered before each daily cocaine session
would prevent the development of compulsive drug seeking. Figure 1 illustrates the impact of N-acetylcysteine pretreatment on
daily cocaine self-administration under extended access conditions (6 h/d). A comparison of daily infusions during each selfadministration session produced a three-way interaction between cocaine treatment, N-acetylcysteine treatment, and selfadministration session (ANOVA: F(10,550) ⫽ 3.05; p ⫽ 0.001).
Post hoc analyses indicated that cocaine self-administering rats
pretreated with saline exhibited escalation, which was evident as
an increase from day 1 in cocaine intake that was significant by
the fifth session, and that this effect was prevented in cocaine
self-administering rats pretreated with N-acetylcysteine (Fig. 1a)
(Dunnett’s t, p ⬍ 0.05). Furthermore, N-acetylcysteine did not
significantly alter the number of cocaine infusions obtained until
escalation of intake was evident in cocaine rats pretreated with
saline (Fig. 1a) (Dunnett’s t, p ⬍ 0.05). The magnitude of escalation is evident when directly comparing the difference in intake
on the last and first sessions (Fig. 1b). Analysis of these data
produced a significant interaction between N-acetylcysteine and
cocaine treatments (ANOVA: F(10,550) ⫽ 3.05; p ⫽ 0.001); post
hoc tests confirmed that only cocaine rats pretreated with saline
exhibited escalation (Dunnett’s t, p ⬍ 0.05).
Figure 2 illustrates the impact of N-acetylcysteine administered before seven daily injections of cocaine on the establishment of behavioral sensitization. A comparison of total distance
traveled on day 1 of the experiment resulted in a significant twoway interaction between time (18 10 min intervals) and cocaine
treatment (ANOVA: F(17,782) ⫽ 14.03; p ⬍ 0.001). Post hoc analyses revealed that all rats treated with cocaine, regardless of
N-acetylcysteine pretreatment, exhibited significantly higher levels of locomotor activity when compared with rats treated with
saline (Dunnett’s t, p ⬍ 0.05) indicating that N-acetylcysteine did
not alter acute cocaine-induced locomotor activity (Fig. 2a). Separate ANOVAs comparing total distance traveled on days 7 and
28 of the experiment each produced a significant three-way interaction between time (18 10 min intervals), N-acetylcysteine
treatment, and cocaine treatment (day 7: F(17,782) ⫽ 1.92, p ⫽
0.01; day 28: F(17,782) ⫽ 2.69, p ⬍ 0.001). Post hoc analyses indicated that both cocaine groups exhibited higher levels of locomotor activity relative to saline controls on days 7 and 28 of the
experiment (Dunnett’s t, p ⬍ 0.05). Furthermore, cocaine rats
pretreated with saline exhibited higher levels of activity relative to
those pretreated with N-acetylcysteine after the last of seven daily
cocaine injections (day 7) and after a cocaine challenge given 21 d
after the last N-acetylcysteine pretreatment (day 28) (Fig. 2b,c)
4

Figure 2. Daily N-acetylcysteine prevents cocaine-induced behavioral sensitization without
altering acute locomotor activity. a– c, Total distance traveled (mean centimeters ⫾ SEM) is
depicted in 10 min intervals (a, b) or summed across the 2 h session (c). Group designations refer
only to treatments on days 1–7, at which time rats received saline or N-acetylcysteine (0 or 60
mg/kg, i.p.) before each of seven daily injections of saline or cocaine (15 mg/kg, i.p., on days 1
and 7; 30 mg/kg, i.p., on days 2– 6). These drug assignments resulted in four groups: Sal–Sal

(N ⫽ 11), NAC–Sal (N ⫽ 11), Sal–Coc (N ⫽ 13), and NAC–Coc (N ⫽ 15). After a 21 d drug-free
period, locomotor activity was measured on day 28 of the experiment after a saline or cocaine
(15 mg/kg, i.p.) challenge in the absence of N-acetylcysteine pretreatment. The arrow indicates
the timing of the saline or cocaine injection administered on day 1 (a, c), day 7 (c), or day 28 (b,
c) of the experiment. a, *Significant difference from interval immediately preceding the saline
or cocaine injection regardless of N-acetylcysteine treatment; Dunnett’s t, p ⬍ 0.05. #Significant difference from rats injected with saline (0 cocaine) regardless of N-acetylcysteine treatment; ANOVA, p ⬍ 0.05. b, *Significant difference from the interval immediately preceding the
saline or cocaine injection; Dunnett’s t, p ⬍ 0.05. #Significant difference from every other
group; Dunnett’s t, p ⬍ 0.05. c, *Significant difference from day 1; Dunnett’s t, p ⬍ 0.05.
#
Significant difference from every other group; Dunnett’s t, p ⬍ 0.05.
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(Dunnett’s t, p ⬍ 0.05). To test for behavioral sensitization, we
compared total distance across all three test days. This ANOVA
produced an interaction between test day, N-acetylcysteine, and
cocaine (F(2,92) ⫽ 3.15; p ⫽ 0.05). Post hoc analyses indicated that
rats pretreated with saline, but not N-acetylcysteine, exhibited
cocaine-induced behavioral sensitization, evident as a significant
increase in cocaine-induced activity on days 7 and 28 relative to
day 1 (Fig. 2c) (Dunnets t, p ⬍ 0.05).
Figure 3 illustrates the impact of repeated N-acetylcysteine
pretreatment on self-administration under short-access conditions (2 h/d) and cocaine-induced reinstatement of extinguished
lever pressing. A comparison of infusions obtained during daily
self-administration sessions with N-acetylcysteine and cocaine
treatments as between-subjects variables and self-administration
session as a within-subjects variable yielded only a main effect of
cocaine (ANOVA: F(1,37) ⫽ 115; p ⬍ 0.001), indicating that
N-acetylcysteine pretreatment did not significantly alter selfadministration under short-access conditions (Fig. 3a).
N-Acetylcysteine administered during self-administration training also failed to alter the mean ⫾ SEM number of extinction
sessions needed to reach criteria relative to cocaine rats pretreated with saline (SEM: 11 ⫾ 2 and 13.6 ⫾ 1.7, respectively; p ⬎
0.05). In contrast, a comparison of lever pressing during the reinstatement test day and the last three extinction sessions produced a three-way interaction between test day, N-acetylcysteine
treatment, and cocaine treatment (ANOVA: F(3,111) ⫽ 3.06; p ⫽
0.03). Post hoc analyses revealed that a cocaine prime reinstated
extinguished drug seeking, evident as a significant increase in
lever pressing on the reinstatement test relative to the last extinction session, but only in rats that had been treated with saline
during cocaine self-administration (Dunnett’s t, p ⬍ 0.05); indeed, this group of rats exhibited significantly higher levels of
responding on the reinstatement test day than all other groups
(Dunnett’s t, p ⬍ 0.05). In contrast, cocaine rats pretreated with
N-acetylcysteine failed to reinstate cocaine-seeking (Dunnett’s t,
p ⬍ 0.05) despite testing 2–3 weeks after the last N-acetylcysteine
treatment (Fig. 3b).
N-Acetylcysteine pretreatment prevents cocaine-induced
changes in extracellular glutamate levels in the nucleus
accumbens
Figure 4 illustrates extracellular basal glutamate levels sampled
from the nucleus accumbens using in vivo microdialysis. An
ANOVA used to compare glutamate levels (in picomoles per microliter) (Fig. 4a) with N-acetylcysteine and cocaine treatment as
between-subject measures and time (nine 20 min samples) as a
repeated measure did not yield a significant interaction between
the variables (F(8,296) ⫽ 1.28; p ⫽ 0.25), nor a main effect of
cocaine (F(1,37) ⫽ 0.54; p ⫽ 0.47), N-acetylcysteine (F(1,37) ⫽ 0.94;
p ⫽ 0.34), or time (F(8,296) ⫽ 1.73; p ⫽ 0.09). A comparison of
basal glutamate (e.g., before cocaine injection) (Fig. 4b) calculated as area under the curve yielded a significant interaction
between N-acetylcysteine and cocaine treatments (ANOVA:
F(1,37) ⫽ 4.05; p ⫽ 0.05). Subsequent post hoc analyses revealed
that a reduction in basal glutamate levels relative to saline controls was evident in rats pretreated with saline before daily cocaine self-administration sessions; this change in extracellular
glutamate was not evident in cocaine rats that had been treated
with N-acetylcysteine during self-administration training even
when sampled 2–3 weeks after the last N-acetylcysteine treatment
(Dunnett’s t, p ⬍ 0.05).
An ANOVA comparing cocaine-evoked glutamate (percent
baseline) (Fig. 4c,d) with N-acetylcysteine and cocaine treatment
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Figure 3. Daily N-acetylcysteine prevents cocaine-induced reinstatement without altering
cocaine self-administration. a, b, Data are depicted as mean ⫾ SEM number of infusions across
daily self-administration sessions (2 h/d) (a) or responses on the active lever during the last
three extinction sessions and the test for cocaine-induced reinstatement (b). Group designations refer only to treatments given during self-administration training, at which time rats
received saline or N-acetylcysteine (60 mg/kg, i.p.) before self-administering saline or cocaine
(0.5 mg/kg, i.v./infusion; 2 h/d). The pretreatment/self-administration drug assignments resulted in four groups: Sal–Sal (N ⫽ 14), NAC–Sal (N ⫽ 6), Sal–Coc (N ⫽ 14), and NAC–Coc
(N ⫽ 7). Seven days after the last self-administration session, rats underwent daily extinction
training in the absence of any drug treatments. This was followed by a test for cocaine-induced
(10 mg/kg, i.p.) reinstatement in the absence of N-acetylcysteine treatment. *Significant difference from the last extinction session; Dunnett’s t, p ⬍ 0.05. #Significant difference from all
other groups; Dunnett’s t, p ⬍ 0.05.

as between-subject measures and time (nine 20 min samples) as a
repeated measure yielded a significant three-way interaction
(F(8,296) ⫽ 2.05; p ⫽ 0.04). Post hoc analyses indicated that cocaine
increased extracellular glutamate relative to the last baseline sample in rats that had been pretreated with saline before cocaine
self-administration (Dunnett’s t, p ⬍ 0.05) (Fig. 4c); this effect
was not obtained in rats pretreated with N-acetylcysteine during
self-administration training (Dunnett’s t, p ⬍ 0.05). Analyzing
glutamate as area under the curve generated from samples collected after the cocaine injection also indicated that only cocaine
rats pretreated with saline exhibited a significant increase in extracellular glutamate. An interaction between N-acetylcysteine
and cocaine treatments group was obtained (F(1,37) ⫽ 4.05; p ⫽
0.05), with post hoc analyses indicating a significant increase in
glutamate in rats pretreated with saline before cocaine self-
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et al., 2005) and cocaine seeking in rodents
(Park et al., 2002; McFarland et al., 2003;
Schmidt et al., 2005). Plasticity involving
cellular mechanisms capable of regulating
glutamate signaling may underlie altered
activation of glutamatergic pathways. As a
result, identifying these mechanisms may
advance our understanding of the neurobiological basis of addiction and facilitate
the development of pharmacotherapies. In
the present report, N-acetylcysteine administered before daily cocaine prevented
the establishment of plasticity-dependent
cocaine-seeking, even when behavior was
assayed 21 d after the last injection of
N-acetylcysteine. N-Acetylcysteine pretreatment also prevented reduced cystine–
glutamate exchange and subsequent
changes in extracellular glutamate in the
nucleus accumbens after repeated cocaine.
Collectively, these data indicate that reduced system xc⫺ function represents part
of the pathological plasticity needed to
generate compulsive drug seeking.
Targeting system xcⴚ to prevent
behavioral plasticity
Figure 4. Daily N-acetylcysteine prevents long-term changes in extracellular glutamate levels in the nucleus accumbens
Repeated cocaine produces a long-term reproduced by repeated cocaine. a, b, Basal glutamate levels (mean ⫾ SEM) are depicted as picomoles per microliter across 20 min
samples (a) or area under the curve calculated using samples collected before the cocaine injection (b). c, d, Cocaine-evoked duction in system xc⫺ activity, which leads
glutamate is presented as percent change from baseline (c) or area under the curve calculated using samples collected after the to abnormal levels of extracellular glutacocaine injection (d). Group designations refer only to treatments given during self-administration training, at which time rats mate in the nucleus accumbens at baseline
received saline or N-acetylcysteine (60 mg/kg, i.p.) before self-administering saline or cocaine (0.5 mg/kg, i.v./infusion; 2 h/d). and after a cocaine injection (Baker et al.,
The pretreatment/self-administration drug assignments resulted in four groups: Sal–Sal (N ⫽ 14), NAC–Sal (N ⫽ 6), Sal–Coc 2003). Acute administration of N-acetyl(N ⫽ 14), and NAC–Coc (N ⫽ 7). Seven days after the last self-administration session, rats underwent daily extinction training in cysteine, a cysteine prodrug used to inthe absence of any drug treatments. Microdialysis was then used to sample extracellular glutamate before and after an acute crease cystine– glutamate exchange, blocks
cocaine challenge (10 mg/kg, i.p.) in the absence of N-acetylcysteine. *Significant difference from Sal–Sal controls; Dunnett’s t, cocaine-evoked glutamate and blunts cop ⬍ 0.05. ⫹Significant difference from the last baseline sample; Dunnett’s t, p ⬍ 0.05. #Significant difference from NAC–Coc caine seeking (Baker et al., 2003). These
rats (c); Dunnett’s t, p ⬍ 0.05.
data are compelling, in part, because they
pose nonvesicular glutamate release by system xc⫺ as a mechanism that may contribadministration relative to saline controls or cocaine rats pretreated
ute to the neurobiological basis of addiction. We explored this
with N-acetylcysteine (Dunnett’s t, p ⬍ 0.05). Although the area
hypothesis in the current studies by assessing the impact of
primarily sampled in this experiment is the nucleus accumbens, the
N-acetylcysteine administered before daily cocaine on the estabmicrodialysis probe for some subjects also extended into the strialishment of drug seeking. Drug seeking was assessed using multum dorsal to the nucleus accumbens or the olfactory tubercles
tiple behavioral paradigms because each may model distinct as(Fig. 5).
pects of addiction. Escalation of cocaine intake during extendedaccess self-administration was used because this may model loss
N-Acetylcysteine pretreatment prevents cocaine-induced
of control over drug use (Ahmed and Koob, 1998; Mantsch et al.,
plasticity involving system xcⴚ
2004; Ahmed and Cador, 2006; Kippin et al., 2006). Interestingly,
Figure 6 illustrates the impact of daily N-acetylcysteine pretreatment on
N-acetylcysteine pretreatments prevented escalation of drug incocaine-induced plasticity involving system xc⫺. A comparison of
take that was evident in cocaine controls. These data are among
[ 35S]cystine transport produced an interaction between N-acetylthe first to indicate that altered glutamate may be necessary for
cysteineandcocainetreatmentconditions(F(1,31) ⫽7.53;p⫽0.01).Post
the escalation of drug intake.
hoc analyses revealed that rats pretreated with saline before cocaine selfBehavioral sensitization is one of the most used paradigms in
administration exhibited reduced [ 35S]cystine transport relative to saattempts to identify the relevance of drug-induced plasticity and
line controls (Dunnett’s t, p ⬍ 0.05). Furthermore, rats pretreated
may model changes in sensitivity to cocaine arising after repeated
with N-acetylcysteine before cocaine self-administration failed to exdrug exposure (Wolf, 1998; Vanderschuren and Kalivas, 2000).
hibit diminished cystine–glutamate exchange, although cystine uptake
In the present study, N-acetylcysteine administered before daily
was measured 23–34 d after the last treatment of either cocaine or
cocaine prevented behavioral sensitization. These data are conN-acetylcysteine (Dunnett’s t, p ⬍ 0.05).
sistent with the preponderance of previous work indicating that
Discussion
excessive glutamatergic signaling is a precipitating event underAbnormal glutamate signaling within corticostriatal pathways
lying sensitization (Pierce et al., 1996; Li et al., 1999; Tzschentke
has been linked to craving in humans (Breiter et al., 1997; Volkow
and Schmidt, 2000; Ghasemzadeh et al., 2003). Moreover, sensi-
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Figure 6. Daily N-acetylcysteine prevents cocaine-induced blunting of system xc⫺ activity
in the nucleus accumbens. Data depict [ 35S]cystine transport restricted to system xc⫺ activity
in nucleus accumbens tissue punches. Group designations refer only to treatments given during
self-administration training at which time rats received saline or N-acetylcysteine (60 mg/kg,
i.p.) before self-administering saline or cocaine (1.0 mg/kg, i.v./infusion; 6 h/d). The
pretreatment/self-administration drug assignments resulted in the following groups: Sal–Sal
(N ⫽ 12), NAC–Sal (N ⫽ 5), Sal–Coc (N ⫽ 7), and NAC–Coc (N ⫽ 11). After an extended
drug-free period (23–34 d), tissue punches were obtained from the nucleus accumbens and
used to measure [ 35S]cystine transport by system xc⫺. *Significant difference from Sal–Sal
controls; Dunnett’s t, p ⬍ 0.05. #Significant difference from NAC–Coc rats; Dunnett’s t, p ⬍
0.05.

plasticity needed for cocaine-induced reinstatement because behavior is measured 2–3 weeks after the last N-acetylcysteine treatment. These data extend our previous observation that acute
N-acetylcysteine given before testing blocks cocaine-primed reinstatement (Baker et al., 2003). Furthermore, our current finding represents one of the first chronic treatments capable of
blocking cocaine-primed reinstatement, which is of particular
importance because long-term treatment will likely be needed to
treat addiction.
N-Acetylcysteine prevented the establishment of plasticitydependent behaviors without altering the acute effects of cocaine
(e.g., locomotor activity). One interpretation of these findings is
that acute N-acetylcysteine is ineffective in blocking behaviors
produced by cocaine; however, this is unlikely for two reasons.
First, acute N-acetylcysteine blocks cocaine-primed reinstatement when administered on the test day (Baker et al., 2003).
Second, repeated N-acetylcysteine in the present study failed to
block cocaine-induced locomotion or self-administration before
escalation. Instead, these data suggest that N-acetylcysteine selectively reverses plasticity-dependent behaviors. In support,
N-acetylcysteine, fails to increase system xc⫺ activity in drugnaive controls (Baker et al., 2003), indicating that it selectively
alters extracellular glutamate in pathological states, which further
supports the utility of this approach in treating addiction.
Figure 5. A schematic illustrating the placement of the 2 mm active membrane portion of
the microdialysis probe for the rats included in the microdialysis study. The active regions of the
microdialysis probes were primarily located in the nucleus accumbens, although regions of the
neostriatum dorsal to the nucleus accumbens as well as the olfactory tubercles were likely
sampled as well.

tized locomotion failed to emerge even when behavior was tested
21 d after the last N-acetylcysteine treatment, indicating that daily
cocaine failed to produce the plasticity necessary for the emergence of behavioral sensitization in rats pretreated with
N-acetylcysteine.
Cocaine-induced reinstatement is dependent on increased
glutamatergic signaling within the prefrontal cortex or nucleus
accumbens (Cornish and Kalivas, 2000; Capriles et al., 2003; McFarland et al., 2003; Baptista et al., 2004; Di Ciano and Everitt,
2004; Suto et al., 2004). In the present study, N-acetylcysteine
administered before daily cocaine prevents the establishment of

Targeting system xcⴚ to prevent plasticity involving
extracellular glutamate
The cysteine prodrug N-acetylcysteine may have blocked the establishment of escalation of drug intake, behavioral sensitization,
and cocaine-primed reinstatement by preventing a persistent reduction in system xc⫺ activity and subsequent changes in extracellular glutamate in the nucleus accumbens. To test this, we
examined the status of cystine– glutamate exchange and extrasynaptic glutamate in the nucleus accumbens in rats treated with
N-acetylcysteine before daily cocaine. The current studies revealed that repeated N-acetylcysteine prevented a long-term reduction in system xc⫺ activity that was evident in cocaine controls. In separate rats, N-acetylcysteine also prevented the
capacity of cocaine to produce a long-term reduction in extrasynaptic basal glutamate in the nucleus accumbens. This is important because this pool of glutamate provides endogenous stimu-
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lation to group II mGluRs (Xi et al., 2002a), which function as
autoreceptors providing constitutive inhibition of synaptic glutamate release (Baskys and Malenka, 1991; Cochilla and Alford,
1998; Hu et al., 1999; Schoepp, 2001; Valenti et al., 2002; Xi et al.,
2002b). Not surprisingly, we observed in the present study that
cocaine failed to elevate extracellular glutamate in the nucleus
accumbens once normal basal levels were restored. Similar to the
above behavioral experiments, the lack of neurochemical changes
was observed at least 2 weeks after the last N-acetylcysteine
treatment.
In the current study, cocaine-induced behavioral plasticity
failed to materialize in the absence of reduced cystine– glutamate
exchange. One interpretation of these findings is that
N-acetylcysteine maintains normal system xc⫺ activity during
repeated cocaine, which in turn prevents persistent changes in the
levels of extracellular glutamate in the nucleus accumbens that
are necessary for plasticity-dependent drug seeking. In support,
previous studies indicate that normalizing extracellular glutamate, particularly after a cocaine prime, would be expected to
block behavioral sensitization and cocaine-primed reinstatement
(Pierce et al., 1998; Li et al., 1999; Tzschentke and Schmidt, 2000;
McFarland and Kalivas, 2001; Baker et al., 2003). Thus, these data
provide compelling evidence that nonvesicular glutamate contributes to pathological brain function, and further establish system xc⫺ as a novel target for disorders involving abnormal glutamate. However, future studies will be needed to confirm the site
of action of N-acetylcysteine because it is possible that
N-acetylcysteine functions through mechanisms distinct from
system xc⫺ or by altering cystine– glutamate exchange in brain
regions other than the nucleus accumbens.
It may seem paradoxical that targeting cystine– glutamate exchange, which increases nonvesicular glutamate, is effective in
reducing cocaine-induced behaviors in rodents or drug craving
and use in humans because these behaviors require increased
glutamate signaling (Cornish and Kalivas, 2000; Baker et al.,
2003; Di Ciano and Everitt, 2003; McFarland et al., 2003; Larowe
et al., 2006; Mardikian et al., 2007). However, this may reflect the
existence of multiple, functionally distinct pools of glutamate.
Cocaine increases glutamate in the synaptic cleft after corticostriatal activation, thereby generating behaviors dependent on
postsynaptic receptor stimulation (Cornish and Kalivas, 2000;
McFarland et al., 2003; Di Ciano and Everitt, 2004; Suto et al.,
2004). Conversely, N-acetylcysteine involves glutamate release
into the extrasynaptic compartment resulting in the stimulation
of group II mGluRs (Baker et al., 2002, 2003; Moran et al., 2005).
Glutamate transporters may partition the two pools by limiting
glutamate overflow from the synapse into the extrasynaptic compartment (Danbolt, 2001), and restricting entry of nonvesicular
glutamate into the synapse (Jabaudon et al., 1999). By stimulating
extrasynaptic group II mGluRs without exerting postsynaptic effects, extrasynaptic glutamate appears to inhibit synaptic pools
(Baker et al., 2002; Moran et al., 2005). To the extent that NR2B
receptors are located outside the synapse, this hypothesis is supported by the recent observation that glutamate release from astrocytes appears to stimulate extrasynaptic, but not synaptic
NMDA receptors (D’Ascenzo et al., 2007).
The present data reveal that system xc⫺ represents a novel
target capable of preventing plasticity that underlies behaviors
used to model aspects of addiction and are consistent with clinical
studies indicating efficacy for N-acetylcysteine as an anticraving
agent for cocaine addiction (Larowe et al., 2006; Mardikian et al.,
2007). Aside from system xc⫺, numerous mechanisms may be
capable of releasing glutamate into the extrasynaptic compart-
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ment including vesicular release from astrocytes (Bezzi et al.,
2004; Zhang et al., 2004), nonvesicular release from astrocytic gap
junction hemichannels (Ye et al., 2003), volume-sensitive organic anion channels (Strange et al., 1996; Basarsky et al., 1999),
or hydrolysis of N-acetylaspartylglutamate (Blakely et al., 1988;
Zhou et al., 2005). Thus, models of brain functioning in the normal and diseased states need to account for the existence of high,
steady-state levels of glutamate in the extrasynaptic space. Moreover, mechanisms contributing to extrasynaptic glutamate represent novel opportunities to regulate glutamate and may contribute to pathological states involving altered excitatory
signaling.
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